NCT06287671 Colorectal Omics and OfCS Proteoglycans
| NCT ID | NCT06287671 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Claus Anders Bertelsen, PhD, MD |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-10-08 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-10-08 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study aims to test proteomics, metabolomics and proteoglycans as predictors of postoperative complications after colorectal surgery and as biomarkers of colorectal cancer. The main questions to answer are: * can these biomarkers predict anastomotic leakages * can these biomarkers predict recurrence after colorectal cancer * can these biomarkers be used as diagnostic tests for colorectal cancer * can these biomarkers be identified in the tumor Participants will undergo elective colorectal resection or stoma closure.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed or with suspicion of colorectal cancer or adenoma, inflammatory bowel disease, late complications to colon diverticulosis, colostomy reversal or other diagnoses requiring colorectal resection. * Patients planned to undergo elective surgical procedures coded as KJFB20-KJFB99, KJFG30-37 or KJGB00-97 according to the Danish modification of the NOMESCO Classification of Surgical Procedures * Able to speak Danish, English, or other languages where professional interpretation is available * Able to give informed consent Exclusion Criteria: * Patients undergoing synchronous: liver resection (patients undergoing metastasectomies can be included); total gastrectomy or cardia resection; Whipple's procedure or another major pancreatic resection (resections of the pancreatic tail can be included); total or partial nephrectomies or cystectomy * Patients previously included in the study * Patients known to be pregnant (pregnancy test not required) * Non-resident in Denmark
Contact & Investigator
Claus A Bertelsen, PhD
STUDY CHAIR
Department of Surgery, Copenhagen University Hospital - North Zealand
Frequently Asked Questions
Who can join the NCT06287671 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06287671 currently recruiting?
Yes, NCT06287671 is actively recruiting participants. Contact the research team at nanna.baekvang.hupfeld.01@regionh.dk for enrollment information.
Where is the NCT06287671 trial being conducted?
This trial is being conducted at Hillerød, Denmark, Viborg, Denmark.
Who is sponsoring the NCT06287671 clinical trial?
NCT06287671 is sponsored by Claus Anders Bertelsen, PhD, MD. The principal investigator is Claus A Bertelsen, PhD at Department of Surgery, Copenhagen University Hospital - North Zealand. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.